Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Curr Drug Targets ; 23(12): 1136-1154, 2022.
Article in English | MEDLINE | ID: mdl-35430989

ABSTRACT

BACKGROUND: Coronavirus disease 2019 (COVID-19) is currently rampant worldwide, resulting in unpredictable harm to humans. High blood levels of cytokines and chemokines have been marked in patients with COVID-19 infection, leading to cytokine storm syndrome. Cytokine storms are violent inflammatory immune responses that reveal the devastating effect of immune dysregulation and the critical role of an effective host immune response. METHODS: Scientometric analysis summarizes the literature on cytokine storms in recent decades and provides a valuable and timely approach to tracking the development of new trends. This review summarizes the pathogenesis and treatment of diseases associated with cytokine storms comprehensively based on scientometric analysis. RESULTS: Field distribution, knowledge structure, and research topic evolution correlated with cytokine storms are revealed, and the occurrence, development, and treatment of disease relevant to cytokine storms are illustrated. CONCLUSION: Cytokine storms can be induced by pathogens and iatrogenic causes and can also occur in the context of autoimmune diseases and monogenic diseases as well. These reveal the multidisciplinary nature of cytokine storms and remind the complexity of the pathophysiological features, clinical presentation, and management. Overall, this scientometric study provides a macroscopic presentation and further direction for researchers who focus on cytokine storms.


Subject(s)
COVID-19 , Cytokine Release Syndrome , Cytokine Release Syndrome/etiology , Cytokines , Humans , SARS-CoV-2
2.
Int J Biol Macromol ; 209(Pt A): 70-82, 2022 Jun 01.
Article in English | MEDLINE | ID: mdl-35351547

ABSTRACT

A colon-specific carrier that can protect drugs from the destruction in the gastrointestinal tract is critical for treating irritable bowel syndrome with diarrhea (IBS-D). In this study, chitosan was cross-linked by the thioketal (TK) bond to serve as a ROS-sensitive core of microspheres. Then the chitosan core was coated with an alginate shell. The alginate/chitosan microspheres can protect puerarin against the destruction and elimination in the gastrointestinal tract and release puerarin at the lesion sites in large quantities. The microspheres were characterized using differential scanning calorimetry, Fourier-transform infrared spectroscopy, and scanning electron microscopy. The swelling study showed that microspheres would shrink in an acidic environment. The in vitro release analysis indicated that little puerarin was released at gastric pH but burst release was observed in simulated colonic fluid containing H2O2. Fluorescent tracer revealed that the fluorescence of microspheres lasted up to 30 h in the colon, which was beneficial to prolong the action time between puerarin and colon. The in vivo studies indicated that puerarin-loaded microspheres are more effective in the treatment of IBS-D than free puerarin. Altogether, the ROS-responsive alginate/chitosan microspheres may be a promising strategy for IBS-D.


Subject(s)
Chitosan , Irritable Bowel Syndrome , Alginates/chemistry , Alginates/therapeutic use , Chitosan/chemistry , Diarrhea/drug therapy , Drug Carriers/chemistry , Glucuronic Acid/chemistry , Glucuronic Acid/therapeutic use , Hexuronic Acids/chemistry , Hexuronic Acids/therapeutic use , Humans , Hydrogen Peroxide , Irritable Bowel Syndrome/drug therapy , Microscopy, Electron, Scanning , Microspheres , Reactive Oxygen Species , Spectroscopy, Fourier Transform Infrared
3.
ACS Nano ; 16(4): 6359-6371, 2022 Apr 26.
Article in English | MEDLINE | ID: mdl-35324149

ABSTRACT

Controllable and visible delivery of therapeutic agents is critical for tumor precise therapy. Tumor targeting and deep penetration of therapeutic agents are still challenging issues for controllable delivery. Visible drug delivery with imaging navigation can optimize the treatment window for personalized medicine. Herein, a biomimetic platelet intelligent vehicle with navigation (IRDNP-PLT) was developed to achieve controllable and visible delivery with a navigation system, a driving system, and a loading system. The platelets acted as engines and drug repositories to exert the target driving and delivery functions. The fluorescent photothermal agent IR-820 was introduced in the platform to offer an imaging navigation for the intelligent platelet vehicle in addition to photothermal therapy. The nanodrug-loaded platelets enabled efficient drug loading and controlled release of the therapeutic payload by encapsulating photothermal-/pH-sensitive chemotherapeutic nanoparticles (PDA@Dox NPs). In in vivo experiments on 4T1 tumor-bearing mice models, IRDNP-PLT performed well in tumor targeting and showed excellent therapeutic efficacy and tumor recurrence prevention ability. The intelligent platelet vehicle achieved the functions of tumor targeting and deep penetration, fluorescence imaging guidance, photocontrolled drug release, and chemo-photothermal combination therapy, suggesting the advancement for tumor precise delivery and efficient therapy.


Subject(s)
Hyperthermia, Induced , Nanoparticles , Neoplasms , Mice , Animals , Phototherapy/methods , Hyperthermia, Induced/methods , Doxorubicin , Blood Platelets , Drug Liberation , Cell Line, Tumor , Drug Delivery Systems/methods , Neoplasms/diagnostic imaging , Neoplasms/drug therapy
4.
Phytomedicine ; 92: 153735, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34601221

ABSTRACT

BACKGROUND: Current antidepressant therapy remains unsatisfactory due to its delayed clinical onset of action and the heterogeneity of depression. Targeting disturbed neurometabolic pathways could provide a novel therapeutic approach for the treatment of depression. Albiflorin is a phytomedicine isolated from the root of Peony (Paeonia albiflora Pall) with excellent clinical tolerance. Until now, the antidepressant-like activities of albiflorin in different subtypes of depression and its effects on neurometabolism are unknown. PURPOSE: The objective of this study was to investigate the rapid antidepressant-like effects of albiflorin in three common animal models of depression and elucidate the pharmaco-metabolic mechanisms of its action using a multi-omics approach. RESULTS: We found that albiflorin produces rapid antidepressant-like effects in chronic unpredictable mild stress (CUMS), olfactory bulbectomy (OBX), and lipopolysaccharide (LPS)-induced murine models of depression. Using a system-wide approach combining metabolomics, lipidomics, and transcriptomics, we showed that the therapeutic effects of albiflorin are highly associated with the rapid restoration of a set of common metabolic abnormities in the hippocampus across all three depression models, including phospholipid and tryptophan metabolism. Further mechanistic analysis revealed that albiflorin normalized the metabolic dysregulation in phospholipid metabolism by suppressing hippocampal cytosolic phospholipases A2 (cPLA2). Additionally, inhibition of cPLA2 overexpression by albiflorin corrects abnormal kynurenine pathway of tryptophan metabolism via the cPLA2-protein kinase B (Akt1)-indoleamine 2,3-dioxygenase 1(IDO1) regulatory loop and directs tryptophan catabolism towards more hippocampal serotonin biosynthesis. CONCLUSION: Our study contributed to a better understanding of the homogeneity in the metabolic mechanisms of depression and established a proof-of-concept for rapid treatment of depression through targeting dysregulated neurometabolic pathways.


Subject(s)
Depression , Tryptophan , Animals , Antidepressive Agents/pharmacology , Bridged-Ring Compounds , Depression/drug therapy , Disease Models, Animal , Hippocampus , Mice , Phospholipids , Stress, Psychological
5.
Drug Deliv ; 28(1): 2137-2149, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34617853

ABSTRACT

Depression is a primary public health problem. However, current antidepressants work slowly, and together with side effects. Herein, the alginate nanogels were constructed to load albiflorin (albiflorin nanogels), which further formed albiflorin nanogel loaded self-assembled thermosensitive hydrogel system (albiflorin-NGSTH) and were used to improve its antidepressant effects. The nanogel showed a nano-scaled particle size and stronger antioxidant activity. Rheological studies showed that albiflorin-NGSTH had a sol-gel transition at approximately 28 °C. Albiflorin-NGSTH quickly entered the brain by intranasal delivery, and had a continuously release for albiflorin. Preliminary results of mice behavioral despair tests found that albiflorin-NGSTH had no effects on independent exploratory behavior and anxiety of the mice, and significantly decreased immobility duration of the mice in tail suspension test (TST). Moreover, the intranasally administrated albiflorin-NGSTH at a low dose improved depressive behavior, decreased levels of proinflammatory cytokines, and repaired neuronal damage of chronic unpredictable mild stress (CUMS) rats, which indicated an excellent potential for depression therapy. The treatment of albiflorin-NGSTH on depressive disorder was achieved by regulating signal pathway related to depression. Therefore, albiflorin-NGSTH has an excellent potential for clinical application in intranasal drug delivery systems.


Subject(s)
Alginates/chemistry , Antidepressive Agents/pharmacology , Bridged-Ring Compounds/pharmacology , Nanogels/chemistry , Administration, Intranasal , Animals , Antidepressive Agents/administration & dosage , Antidepressive Agents/pharmacokinetics , Brain/drug effects , Bridged-Ring Compounds/administration & dosage , Bridged-Ring Compounds/pharmacokinetics , Chemistry, Pharmaceutical , Cytokines/drug effects , Depression/drug therapy , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Carriers/chemistry , Drug Liberation , Male , Mice , Mice, Inbred ICR , Particle Size , Rats , Rats, Sprague-Dawley , Surface Properties
6.
Food Funct ; 12(5): 2211-2224, 2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33595580

ABSTRACT

As a functional bowel disorder, irritable bowel syndrome (IBS), especially IBS-diarrhea (IBS-D), affects approximately 9-20% of the population worldwide. Classical treatments for IBS usually result in some side effects and intestinal microbial disorders, which inhibit the clinical effects. Natural edible medicines with beneficial effects and few side effects have received more attention in recent years. Puerarin is the main active ingredient in pueraria and has been used in China to treat splenasthenic diarrhea and as a natural food in folk medicine for hundreds of years. However, there have been no reports of using puerarin in the treatment of IBS-D, and the underlying mechanism is also still unclear. In this study, a comprehensive model that could reflect the symptoms of IBS-D was established by combining neonatal maternal separation (NMS) and adult colonic acetic acid stimulation (ACAAS) in rats. The results showed that puerarin could reverse the abdominal pain and diarrhea in IBS-D rats. The therapeutic effect was realized by regulating the richness of the gut microbiota to maintain the stabilization of the intestinal micro-ecology. Furthermore, the possible mechanism might be related to the activity of the hypothalamic-pituitary-adrenal (HPA) axis by the suppressed expression of corticotropin-releasing hormone receptor (CRF) 1. At the same time, intestinal function was improved by enhancing the proliferation of colonic epithelial cells by upregulating the expression of p-ERK/ERK and by repairing the colonic mucus barrier by upregulating occludin expression. All these results suggest that puerarin could exert excellent therapeutic effects on IBS-D.


Subject(s)
Colon , Diarrhea/metabolism , Irritable Bowel Syndrome/metabolism , Isoflavones/pharmacology , Pueraria/chemistry , Animals , Behavior, Animal/drug effects , Colon/drug effects , Colon/metabolism , Defecation/drug effects , Female , Gastrointestinal Microbiome/drug effects , Male , Rats , Rats, Sprague-Dawley
7.
Int J Biol Macromol ; 168: 93-104, 2021 Jan 31.
Article in English | MEDLINE | ID: mdl-33278444

ABSTRACT

Acute liver failure is an uncommon and dramatic clinical syndrome with a high risk of mortality. Previous treatments existed some limitations of poor bioavailability and targeting the efficiency of drugs. In this study, a novel glycyrrhizin mediated liver-targeted alginate nanogels, which can deliver the antioxidant quercetin to the liver for the treatment of acute liver injury. In vitro radical scavenging results showed that the antioxidant activity of quercetin was increased 81-fold. The tissue distribution results indicated that glycyrrhizin-mediated nanogels showed stronger fluorescence intensity in the liver, which improved liver targeting and therapeutic efficacy. Quercetin-glycyrrhizin nanogels were more effective at restoring liver injury as indicated on serum markers, including alanine transaminase, aspartate aminotransferase, and total bilirubin. The histopathology result showed that quercetin-glycyrrhizin nanogels reversed liver damage. Oxidative parameters of malondialdehyde and glutathione s-transferase were decreased, which provided supporting evidence of antioxidation. Moreover, quercetin-glycyrrhizin nanogels were more effective in down-regulating the inflammation-related gene expression of tumor necrosis factor-α, interleukin-6, inducible nitric oxide synthase and monocyte chemotactic protein-1. In conclusion, the novel glycyrrhizin mediated liver-targeted alginate nanogels might be a promising treatment for acute liver failure.


Subject(s)
Alginates/chemistry , Glycyrrhizic Acid/metabolism , Quercetin/administration & dosage , Alanine Transaminase/blood , Alginates/pharmacology , Animals , Antioxidants/pharmacology , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury/pathology , China , Glycyrrhizic Acid/chemistry , Inflammation/drug therapy , Liver/drug effects , Liver Failure, Acute/metabolism , Male , Mice , Nanogels/administration & dosage , Nanogels/chemistry , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , Quercetin/pharmacology , Tumor Necrosis Factor-alpha/metabolism
8.
Article in English | MEDLINE | ID: mdl-32565856

ABSTRACT

Changes in gut motility and visceral hypersensitivity are two major features of irritable bowel syndrome (IBS). Current drug treatments are often poorly efficacious, with many side effects for patients with IBS. Complementary therapies, such as acupuncture or abdominal massage, have received more attention in recent years. In this study, a rat model of IBS with diarrhea (IBS-D) was established by instillation of acetic acid from the colon. The effects of abdominal massage on changes in gut motility, visceral hypersensitivity, and the possible mechanism were investigated. Continuous abdominal massage could decrease the stool consistency score and increase the efflux time of glass beads compared with model groups, while also decreasing mast cell counts in IBS-D rats. The mRNA and protein expressions of neuronal nitric oxide synthase (nNOS), choline acetyl transferase (CHAT), and protein gene product 9.5 (PGP9.5) were significantly upregulated by continuous abdominal massage compared with model groups. Continuous abdominal massage also improved the ultrastructure of enteric glial cells (EGCs) by decreasing the number of mitochondria and increasing the level of the heterochromatin. Meanwhile, continuous abdominal massage could upregulate the expression of glial cell line-derived neurotrophic factor (GDNF) and P-Akt/Akt. Furthermore, it could reduce visceral hypersensitivity and improve the IBS-D symptoms by regulating the phosphoinositide 3-kinase (PI3K)-Akt pathway, which would provide a novel method for the treatment of IBS-D in the clinical setting.

9.
Int J Pharm ; 586: 119550, 2020 Aug 30.
Article in English | MEDLINE | ID: mdl-32554031

ABSTRACT

Although icariin has been reported to have antidepressant-like effects in different animal models, its poor oral bioavailability and low efficiency of delivery to the brain limit its application. In this study, icariin nanogels were prepared by reverse microemulsion methods to improve its poor water solubility. Then, we developed an icariin nanogel loaded self-assembled thermosensitive hydrogel system (icariin-NGSTH) to deliver icariin via a noninvasive, direct nose-to-brain delivery route for the treatment of depression. The in vivo distribution was investigated by fluorescence imaging with rhodamine B-labeled nanogels. The antidepressant efficacy of icariin-NGSTH was evaluated in behavioral despair tests and the chronic unpredictable mild stress (CUMS) model. The results showed that icariin-NGSTH had a zero-order kinetics release in the first 10 h. Icariin-NGSTH led to rapid brain distribution within 30 min. Icariin-NGSTH significantly reduced the duration of immobility in the tail suspension test (TST) and forced swim test (FST). Compared with oral administration, intranasally administered icariin-NGSTH had a fast-acting antidepressant effect in the TST and FST. Moreover, icariin-NGSTH increased body weight and sucrose preference, reversed abnormal plasma levels of testosterone, interleukin-6 (IL-6) and prostaglandin E2 (PGE2), and repaired neuronal damage in the hippocampi of CUMS rats. These results indicated that icariin-NGSTH at a low dose produced a significant antidepressant effect. As a complex drug delivery system, intranasally administered icariin-NGSTH is a rapid and effective treatment for depression, increasing the antidepressant-like activity of icariin.


Subject(s)
Antidepressive Agents/pharmacology , Depression/drug therapy , Flavonoids/pharmacology , Stress, Psychological/drug therapy , Administration, Intranasal , Animals , Antidepressive Agents/administration & dosage , Antidepressive Agents/pharmacokinetics , Brain/drug effects , Disease Models, Animal , Drug Delivery Systems , Flavonoids/administration & dosage , Flavonoids/pharmacokinetics , Hydrogels , Male , Mice , Mice, Inbred ICR , Nanogels , Rats , Rats, Sprague-Dawley , Tissue Distribution
10.
Biomater Sci ; 8(10): 2853-2865, 2020 May 21.
Article in English | MEDLINE | ID: mdl-32270794

ABSTRACT

The efficacy of antidepressant therapy is frequently limited by challenges related to the potential to reach the brain. The development of new strategies to deliver more antidepressants to the brain so as to bypass the blood-brain barrier (BBB) is beneficial for the treatment of nervous system diseases, especially depression. Here, we have reported an unconventional strategy by the intranasal delivery of berberine with an in situ thermoresponsive hydrogel as the holder in the nasal cavity to improve its antidepressant-like activity. A berberine/hydroxylpropyl-ß-cyclodextrin (HP-ß-CD) inclusion complex was first prepared to improve the solubility of berberine and loaded into a thermoresponsive hydrogel system of poloxamers. A radioactive tracer of 125I-labeled berberine was used to investigate brain targeting. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) was performed to study the pharmacokinetic change in the hippocampus. Monoamine neurotransmitters were analyzed in a reserpine-induced depression model, and metabolomic analysis of the hippocampus was performed in a chronic unpredictable mild stress (CUMS)-induced depression model. The radioactive tracer analysis manifested that the thermoresponsive hydrogel administered intranasally could maintain a high concentration gradient of berberine to the brain, and the relative bioavailability of berberine was enhanced approximately by 110 times that of the oral berberine/HP-ß-CD inclusion complex in the hippocampus. The thermoresponsive hydrogel system resulted in similar or better antidepressant-like efficacy even with a lower dosage in reserpine and CUMS-induced depression in rats. The pharmacometabolomics analysis revealed that in addition to increasing the hippocampal monoamine levels, berberine via intranasal administration exhibited a unique mechanism by restoring the mitochondrial dysfunction as well as phospholipid and sphingolipid abnormalities as compared to intragastric (IG) administration. We consider this a safer and more effective strategy with a lower dosage than traditional oral drugs for the treatment of depression.


Subject(s)
Antidepressive Agents/pharmacology , Berberine/pharmacology , Depression/drug therapy , Drug Delivery Systems , Hydrogels/pharmacology , Temperature , Administration, Intranasal , Animals , Antidepressive Agents/administration & dosage , Berberine/administration & dosage , Blood-Brain Barrier/drug effects , Disease Models, Animal , Hydrogels/administration & dosage , Male , Rats , Rats, Wistar , Stress, Psychological
11.
Complement Ther Med ; 48: 102248, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31987254

ABSTRACT

INTRODUCTION: Diabetes is closely related with depression. Gardenia fructus antidepressant formula (GFAF) is a Chinese herbal medicine that may be beneficial for depression in diabetic patients. This study aimed to evaluate the efficacy and safety of GFAF for depression in diabetes patients. METHODS: Randomized controlled trials (RCTs) were included. The patients were diagnosed as having diabetes mellitus with depression. The experimental interventions included GFAF alone or combined with another active treatment. The control interventions included no treatment, placebo or another active treatment. The primary outcome was reduction in the Hamilton Depression Scale (HAMD) scores. Secondary outcomes included reduction in the Self-rating Depression Scale (SDS) scores, response rate, adverse events, etc. PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan fang database and Chinese Science and Technology Periodicals database (VIP) were searched from inception to May 2019 for potentially eligible studies. The meta-analysis was performed using RevMan 5.3 software. RESULTS: We identified 12 eligible RCTs including 822 diabetes patients with depression. Results of meta-analysis showed that the HAMD score was significantly reduced following GFAF treatment compared with no antidepressant treatment (SMD: -2.53, 95% CI: -4.80 to -0.27, P = 0.03). Another meta-analysis indicated that patients taking GFAF alone had lower HAMD scores compared with selective serotonin reuptake inhibitors (SSRI) treatment alone (SMD: -0.62, 95% CI: -1.07 to -0.18, P = 0.006). The HAMD scores in the GFAF plus SSRI treatment group were significantly decreased compared with the SSRI treatment group (SMD: -0.37, 95% CI: -0.69 to -0.06, P = 0.02). The same pattern of change was identified with the SDS scores. CONCLUSION: GFAF may be considered an alternative treatment for depression in patients with diabetes. However, more large-scale and well-designed RCTs are warranted.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/drug therapy , Diabetes Mellitus , Drugs, Chinese Herbal/therapeutic use , Gardenia , Humans , Randomized Controlled Trials as Topic , Surveys and Questionnaires
12.
Theranostics ; 9(21): 6239-6255, 2019.
Article in English | MEDLINE | ID: mdl-31534548

ABSTRACT

Nanocarrier drug delivery systems (NDDS) have been paid more attention over conventional drug delivery system for cancer therapy. However, the efficacy is hampered by the fast clearance of activated macrophage from the blood circulation system. In this study, glycyrrhizin (GL) was introduced into alginate (ALG) nanogel particles (NGPs) to construct multifunctional delivery vehicle to decrease the fast clearance of activated macrophage and enhance the anticancer efficacy with the combination therapy of GL and doxorubicin (DOX). Methods: We firstly synthesized the GL-ALG NGPs with intermolecular hydrogen bond and ionic bond as the multifunctional delivery vehicle. The immune response and phagocytosis of macrophage on GL-ALG NGPs were investigated on RAW 264.7 macrophages. The pharmacokinetic study of DOX loaded in GL-ALG NGPs was performed in rats. The active targeting effects of GL-ALG NGPs were further studied on hepatocellular carcinoma cell (HepG2) and H22 tumor-bearing mice. Moreover, the anticancer molecular mechanism of DOX/GL-ALG NGPs was investigated on HepG2 cells in vitro and tumor-bearing mice in vivo. Results: GL-ALG NGPs could not only avoid triggering the immuno-inflammatory responses of macrophages but also decreasing the phagocytosis of macrophage. The bioavailability of DOX was increased about 13.2 times by DOX/GL-ALG NGPs than free DOX in blood. The mice with normal immune functions used in constructing the tumor-bearing mice instead of the nude mouse also indicated the good biocompatibility of NGPs. GL-mediated ALG NGPs exhibited excellent hepatocellular carcinoma targeting effect in vitro and in vivo. The results suggested that the anticancer molecular mechanism of the combination therapy of glycyrrhizin and doxorubicin in ALG NGPs was performed via regulating apoptosis pathway of Bax/Bcl-2 ratio and caspase-3 activity, which was also verified in H22 tumor-bearing mice. Conclusion: DOX/GL-ALG NGPs could attenuate the activation of macrophage and enhance the therapeutic efficacy for hepatocellular carcinoma. Our results suggest that the combination therapy would provide a new strategy for liver cancer treatment.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Doxorubicin/administration & dosage , Drug Delivery Systems , Glycyrrhizic Acid/administration & dosage , Liver Neoplasms/drug therapy , Nanogels/administration & dosage , Alginates/administration & dosage , Animals , Doxorubicin/chemistry , Doxorubicin/pharmacokinetics , Drug Therapy, Combination , Glycyrrhizic Acid/chemistry , Glycyrrhizic Acid/pharmacokinetics , Hep G2 Cells , Humans , Macrophages/drug effects , Male , Mice , Mice, Nude , RAW 264.7 Cells , Rats, Sprague-Dawley , Tissue Distribution
13.
Int J Pharm ; 570: 118644, 2019 Oct 30.
Article in English | MEDLINE | ID: mdl-31465837

ABSTRACT

Colitis-associated colorectal cancer (CAC) is a common malignancy that develops in chronically inflamed mucosa and is usually accompanied by metastases at other sites. Puerarin, a natural isoflavone isolated from the root of the Pueraria lobata (Willd.) Ohwi, has potential anti-colon cancer activity. However, the poor solubility and low bioavailability of puerarin has restricted its application in the pharmaceutical industry. In the present study, pH-responsive alginate microspheres loaded with puerarin were prepared by emulsification/internal gelation for targeted treatment of colitis-associated colorectal cancer. Herein, puerarin, as an active drug, could participate in the construction of alginate microspheres with hydrogen bonding. The microspheres exhibited pH-responsive release behavior with little release of puerarin in simulated gastric fluid and high amounts (approximately 55%) of release in simulated colonic fluid. A fluorescence tracer indicated microspheres had high retention time of more than 20 h in the colon. Meanwhile, puerarin-loaded alginate microspheres not only significantly decreased the inflammatory response by downregulating the levels of pro-tumorigenic cytokines, but they reduced tumorigenesis and metastasis by inhibiting epithelial-mesenchymal transitions in AOM/DSS-induced colitis-associated colorectal cancer in mice. The overall results suggested that puerarin-loaded alginate microspheres could effectively inhibit development of colonic tumors, which could be developed as a promising therapeutic strategy for colitis-associated colorectal cancer.


Subject(s)
Carcinogenesis/drug effects , Colitis/complications , Colon/drug effects , Colonic Neoplasms/drug therapy , Colonic Neoplasms/etiology , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/etiology , Isoflavones/pharmacology , Alginates/chemistry , Animals , Body Fluids/drug effects , Down-Regulation/drug effects , Epithelial-Mesenchymal Transition/drug effects , Hydrogen Bonding , Hydrogen-Ion Concentration , Inflammation/drug therapy , Intestinal Mucosa/drug effects , Isoflavones/chemistry , Male , Mice , Mice, Inbred BALB C , Microspheres
14.
Food Funct ; 10(8): 4533-4545, 2019 Aug 01.
Article in English | MEDLINE | ID: mdl-31264676

ABSTRACT

Gardenia blue pigments derived from genipin reacting with amino acids have been used as natural food colorants for nearly 30 years in East Asia. However, their pharmacological effects, especially antidepressant-like effects, have not been reported so far. In this study, one of the gardenia blue pigments, was obtained from the reaction of genipin with tyrosine (genipin-tyrosine derivant (GTD)), and its antidepressant-like effects were investigated in lipopolysaccharide (LPS) or chronic unpredictable mild stress (CUMS) models. The results showed that GTD could attenuate depressive-like behaviors in both animal models. GTD reversed the LPS-induced cytokine increase of TNF-α, IL-6, and corticosterone (CORT) in mice plasma and hippocampus. In CUMS rats, GTD treatment significantly reduced hypothalamic-pituitary-adrenal (HPA) axis-related stress hormone levels in plasma including those of CORT, adrenocorticotropic hormone (ACTH), and corticotropin-releasing hormone (CRH). Besides, GTD increased plasma testosterone and hippocampal brain-derived neurotrophic factor (BDNF) levels in CUMS rats. GTD increased serotonin (5-HT), dopamine (DA), and norepinephrine (NE) in rat hippocampus and corpus striatum. Consistently, hippocampal metabolomic analysis demonstrated that GTD restored monoamine neurotransmitter metabolism, mitochondrial oxidative function, and membrane structural integrity. Our data suggested that GTD produced antidepressant-like activity through the restoration of the HPA axis hormone balance and the regulation of neurotransmitter release.


Subject(s)
Antidepressive Agents/administration & dosage , Depression/drug therapy , Gardenia/chemistry , Iridoids/chemistry , Pigments, Biological/administration & dosage , Plant Extracts/administration & dosage , Tyrosine/chemistry , Animals , Antidepressive Agents/chemistry , Brain-Derived Neurotrophic Factor/metabolism , Corticosterone/metabolism , Depression/genetics , Depression/metabolism , Depression/psychology , Hippocampus/drug effects , Hippocampus/metabolism , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Mice , Mice, Inbred C57BL , Pigments, Biological/chemistry , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , Plant Extracts/chemistry , Rats , Rats, Sprague-Dawley , Serotonin/metabolism
15.
J Biomed Mater Res A ; 106(12): 3292-3302, 2018 12.
Article in English | MEDLINE | ID: mdl-30242952

ABSTRACT

Injectable hydrogels have been paid more attentions on cell therapy and tissue regeneration resulting from the applications in minimally invasive surgical procedures with ease of handling and complete filling of defect area. Here, a biodegradable and injectable in situ hydrogel formed by glycyrrhizin (GL), alginate (Alg), and calcium (Ca) was developed for three-dimensional (3D) cell culture. Differential scanning calorimetry (DSC), X-ray diffraction (XRD), scanning electron microscope (SEM) and rheology analysis were performed to characterize GL-Alg-Ca hydrogel and evaluate its formation mechanism, properties, and morphology. The biocompatibility of hydrogel was investigated by cell viability, morphology, and liver specific functions. The results of DSC, XRD, and rheology suggested that hydrogel was homogenous complex with stable structure and well viscoelasticity. Human hepatoma HepG2 cells cultured in hydrogels showed well morphology. Compared with the control group, cells in hydrogels showed good biocompatibility, and could maintain the viability, proliferation and liver function for longer periods of time. Furthermore, the hydrogel improved the mRNA expression of cytochrome P450, which were key enzyme to the metabolization of hepatocytes. The GL-Alg-Ca hydrogel could be a potential 3D cells culture system for liver tissue engineering. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 3292-3302, 2018.


Subject(s)
Alginates/chemistry , Calcium/chemistry , Glycyrrhizic Acid/chemistry , Hydrogels/chemistry , Liver/cytology , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Alginates/administration & dosage , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Calcium/administration & dosage , Cell Proliferation , Cell Survival , Glycyrrhizic Acid/administration & dosage , Hep G2 Cells , Hepatocytes/cytology , Hepatocytes/metabolism , Humans , Hydrogels/administration & dosage , Injections , Liver/metabolism , Materials Testing , Rheology
16.
J Orthop Res ; 36(5): 1415-1424, 2018 05.
Article in English | MEDLINE | ID: mdl-29058779

ABSTRACT

Osteoporosis is a disease characterized by low bone mass and progressive destruction of bone microstructure, resulting in increasing the risk of fracture. Icariin (ICA) as a phytoestrogen shows osteogenic effects, and the mechanical stimulation has been demonstrated the improving effect on osteoporosis. The objective of this study was to investigate the effect of ICA in combination with constrained dynamic loading (CDL) stimulation on osteoporosis in ovariectomized (OVX) mice. The serum hormone levels, bone turnover markers, trabecular architecture, ulnar biomechanical properties, and the expression of osteoblast-related gene (alkaline phosphatase, ALP; osteocalcin, OCN; bone morphogenetic protein-2, BMP-2; Collagen I (α1), COL1; osteoprotegerin, OPG) and osteoclast-related genes (receptor activators of NF-κB ligand, RANKL; tartrate-resistant acid phosphatase, TRAP) were analyzed. The results showed that ICA + CDL treatment could increase the osteocalcin (20.85%), estradiol levels (20.61%) and decrease the TRAP activity (26.27%) significantly than CDL treatment. The combined treatment attenuated bone loss and biomechanical decrease more than single use of CDL treatment. ICA + CDL treatment significantly up-regulated the level of osteoblast-related gene expression and down-regulated the osteoclast-related genes expression; moreover, the combined treatment increased the ratio of OPG/RANKL significantly compared to ICA (72.83%) or CDL (65.63%) treatment alone. The present study demonstrates that icariin in combination with constrained dynamic loading treatment may have a therapeutic advantage over constrained dynamic loading treatment alone for the treatment of osteoporosis, which would provide new evidence for the clinical treatment of osteoporosis. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1415-1424, 2018.


Subject(s)
Flavonoids/therapeutic use , Osteoporosis/therapy , Stress, Mechanical , Animals , Biomechanical Phenomena , Bone Remodeling , Collagen Type I/genetics , Estradiol/blood , Female , Mice , Mice, Inbred ICR , Osteoporosis/blood , Osteoprotegerin/analysis , Ovariectomy , RANK Ligand/analysis
17.
Int J Pharm ; 515(1-2): 176-185, 2016 Dec 30.
Article in English | MEDLINE | ID: mdl-27713029

ABSTRACT

In recent years, oral colon specific drug delivery system has been paid more attention in the treatment of inflammatory bowel disease (IBD). As the special pH condition in gastrointestinal tract, the challenge for treatment of IBD was that the colon drug delivery system should endure the low pH in stomach and release drugs quickly in high pH in colon. Icariin with the poor solubility and low bioavailability limited the treatment of many diseases in clinic. In this study, the protective mechanism of alginate-chitosan microspheres loaded with icariin were investigated with trinitrobenzene sulfonic acid (TNBS)/ethanol induced colonic mucosal injury in rats. The results of drug release showed that the icariin loaded into microspheres released only 10% in simulated gastric fluid and a high amount of 65.6% released in simulated colonic fluid. The fluorescence tracer indicated high retention of targeted microspheres more than 12h in colon. The microspheres loaded with icariin could not only reduce the colonic injury by decreasing the colon mucosa damage index in rats, but also reduce the inflammatory response by reducing the production and gene expression of inflammatory mediators and cytokines in colonic mucosa. All the results indicate that targeted microspheres loaded with icariin could exert the colon-protective effects through reducing the inflammatory response, which would be developed as a potential drug controlled release system for treatment of ulcerative colitis.


Subject(s)
Alginates/chemistry , Chitosan/chemistry , Colon/drug effects , Flavonoids/chemistry , Flavonoids/pharmacology , Animals , Biological Availability , Colitis, Ulcerative/drug therapy , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacology , Drug Carriers/chemistry , Drug Delivery Systems/methods , Flavonoids/metabolism , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Inflammation/drug therapy , Inflammatory Bowel Diseases/drug therapy , Intestinal Mucosa/drug effects , Male , Microspheres , Rats , Rats, Sprague-Dawley , Solubility , Trinitrobenzenesulfonic Acid/chemistry
18.
J Biomed Mater Res A ; 104(8): 1863-70, 2016 08.
Article in English | MEDLINE | ID: mdl-27027247

ABSTRACT

In liver tissue engineering, scaffolds with porous structure desgined to supply nutrient and oxygen exchange for three-dimensional (3-D) cells culture, and maintain liver functions. Meanwhile, genipin, as a natural crosslinker, is widely used to crosslink biomaterials in tissue engineering, with lower cytotoxicity and better biocompatibility. In present study, chitosan/gelatin 3-D scaffolds crosslinked by genipin, glutaraldehyde or 1-(3-dimethylaminopropyl)-3-ethyl-carbodimide hydrochloride (EDC) were prepared and characterized by Fourier-transform infrared (FT-IR) and scanning electron microscopy (SEM). The biocompatibility of chitosan/gelatin scaffolds corsslinked with different crosslinkers was investigated by cell viability, morphology and liver specific functions. The result showed that the 1% and 2% genipin crosslinked chitosan/gelatin scaffolds possess ideal porosity. The genipin crosslinked 3-D scaffolds possessed the best biocompatibility than that of the others, and maintained liver specific functions when HepG2 cells seeded on scaffolds. The cellular morphology of HepG2 cells seeded on scaffolds showed that cells could penetrate into the scaffolds and proliferate significantly. Therefore, genipin crosslinked chitosan/gelatin scaffolds could be a promising biomaterial used in liver tissue engineering. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1863-1870, 2016.


Subject(s)
Chitosan/chemistry , Cross-Linking Reagents/chemistry , Gelatin/chemistry , Iridoids/chemistry , Liver/physiology , Tissue Scaffolds/chemistry , Animals , Cattle , Cell Movement , Cell Proliferation , Cell Shape , Hep G2 Cells , Humans , Imaging, Three-Dimensional , Spectroscopy, Fourier Transform Infrared , Tissue Engineering/methods
19.
J Orthop Res ; 34(9): 1557-68, 2016 09.
Article in English | MEDLINE | ID: mdl-26748661

ABSTRACT

Targeting activated macrophages using anti-inflammatory phytopharmaceuticals has been proposed as general therapeutic approaches for rheumatic diseases. Besides macrophages, chondrocytes are another promising target of anti-inflammatory agents. Tetrandrine is a major bisbenzylisoquinoline alkaloid isolated from Stephania tetrandrae S. Moore which has been used for 2,000 years as an antirheumatic herbal drug in China. Although, the anti-inflammatory effect of tetrandrine has been demonstrated, the mechanism has not been clearly clarified. In this study, we designed a comprehensive anti-inflammatory evaluation system for tetrandrine, including complete Freund's adjuvant (CFA)-induced arthritis rat, LPS-induced macrophage RAW 264.7 cells, and chondrogenic ATDC5 cells. The results showed that tetrandrine alleviated CFA-induced foot swelling, synovial inflammation, and pro-inflammatory cytokines secretion. Tetrandrine could inhibit IL-6, IL-1ß, and TNF-α expression via blocking the nuclear translocation of nuclear factor (NF)-κB p65 in LPS-induced RAW 264.7 cells. Moreover, ATDC5 cells well responded to LPS induced pro-inflammatory mediators secretion and tissue degradation, and tetrandrine could also inhibit the production of nitric oxide and prostaglandin E2 , as well as the expression of matrix metalloproteinase (MMP)-3 and tissue inhibitor of metalloproteinase (TIMP)-1 via inhibiting IκBα phosphorylation and degradation. In conclusion, the results showed that one of the anti-inflammatory mechanisms of tetrandrine was inhibiting IκBα and NF-κB p65 phosphorylation in LPS-induced macrophage RAW 264.7 cells and chondrogenic ATDC5 cells. Moreover, we introduce a vigorous in vitro cell screening system, LPS-induced murine macrophage RAW 264.7 cells coupling chondrogenic ADTC5 cells, for screening anti-rheumatic drugs. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1557-1568, 2016.


Subject(s)
Arthritis, Experimental/drug therapy , Benzylisoquinolines/therapeutic use , Immunosuppressive Agents/therapeutic use , NF-kappa B/metabolism , Animals , Arthritis, Experimental/metabolism , Benzylisoquinolines/pharmacology , Cell Line , Drug Evaluation, Preclinical , Immunosuppressive Agents/pharmacology , Inflammation Mediators/metabolism , Interleukin-1beta/blood , Male , Mice , Phytotherapy , Random Allocation , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/blood
20.
Drug Des Devel Ther ; 9: 6151-65, 2015.
Article in English | MEDLINE | ID: mdl-26640368

ABSTRACT

Zuojin Pill (ZJP), a traditional Chinese medicine formula, consists of Coptis chinensis Franch. and Evodia rutaecarpa (Juss.) Benth. in a ratio of 6:1 (w/w) and was first recorded in "Danxi's experiential therapy" for treating gastrointestinal disorders in the 15th century. However, the poor solubility of alkaloids from ZJP restricted the protective effect in treating gastritis and gastric ulcer. The aim of the study was to investigate the protective mechanism of mucoadhesive microspheres loaded with alkaloids from C. chinensis Franch. and E. rutaecarpa (Juss.) Benth. on ethanol-induced acute gastric mucosal injury in rats. Surface morphology, particle size, drug loading, encapsulation efficiency, in vitro drug release, mucoadhesiveness, and fluorescent imaging of the microspheres in gastrointestinal tract were studied. The results showed that the mucoadhesive microspheres loaded with alkaloids could sustain the release of drugs beyond 12 hours and had gastric mucoadhesive property with 82.63% retention rate in vitro. The fluorescence tracer indicated high retention of mucoadhesive microspheres within 12 hours in vivo. The mucoadhesive microspheres loaded with alkaloids could reduce the gastric injury by decreasing the mucosal lesion index, increasing the percentage of inhibition and increasing the amount of mucus in the gastric mucosa in an ethanol-induced gastric mucosal injury rat model. Moreover, the mucoadhesive microspheres loaded with alkaloids reduce the inflammatory response by decreasing the levels of tumor necrosis factor-α (TNF-α), interleukin 1ß (IL-1ß), downregulating the mRNA expression of inducible nitric oxide synthase, TNF-α, and IL-1ß in gastric mucosa. All the results indicate that mucoadhesive microspheres loaded with alkaloids could not only increase the residence time of alkaloids in rat stomach, but also exert gastroprotective effects through reducing the inflammatory response on ethanol-induced gastric mucosal damage. Thus, these microspheres could be developed as a potential controlled release drug for treatment of gastric ulcer.


Subject(s)
Alginates/chemistry , Alkaloids/pharmacology , Anti-Ulcer Agents/pharmacology , Chitosan/pharmacology , Coptis/chemistry , Drug Carriers , Drugs, Chinese Herbal/pharmacology , Ethanol , Evodia/chemistry , Gastric Mucosa/drug effects , Stomach Ulcer/prevention & control , Adhesiveness , Alkaloids/chemistry , Alkaloids/isolation & purification , Animals , Anti-Ulcer Agents/chemistry , Anti-Ulcer Agents/isolation & purification , Chemistry, Pharmaceutical , Chitosan/analogs & derivatives , Cytoprotection , Disease Models, Animal , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Inflammation Mediators/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Male , Mice, Inbred ICR , Microspheres , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Phytotherapy , Plants, Medicinal , Rats, Sprague-Dawley , Solubility , Stomach Ulcer/chemically induced , Stomach Ulcer/genetics , Stomach Ulcer/metabolism , Stomach Ulcer/pathology , Time Factors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...